Estrella Immunopharma Inc. (ESLA) — Financial Flexibility Index
Estrella Immunopharma Inc. (ESLA) has a Financial Flexibility Index of -0.19x as of June 2026. Free cash flow of $-1.78 Million (operating CF $-1.78 Million minus capex $0.00) represents 0% of total liabilities ($9.26 Million). Check ESLA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Estrella Immunopharma Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Estrella Immunopharma Inc. across 5 annual periods. For the full cash flow conversion analysis, see ESLA operating cash flow.
Annual Financial Flexibility Index for Estrella Immunopharma Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Estrella Immunopharma Inc.. Explore Estrella Immunopharma Inc. (ESLA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.13x | $-1.79 Million | $-1.79 Million | $13.54 Million | ▲ +87.3% |
| 2024 | -1.04x | $-3.11 Million | $-3.11 Million | $3.00 Million | ▲ +98.8% |
| 2023 | -88.92x | $-16.07 Million | $-16.07 Million | $180.70K | ▼ -24738.1% |
| 2022 | -0.36x | $-1.04 Million | $-1.04 Million | $2.92 Million | ▼ -48.0% |
| 2021 | -0.24x | $-1.44 Million | $-1.44 Million | $5.96 Million | — |